|
TWF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47660000000094E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.78480000000625E-05 |
| Normal-vs-Stage2 |
9.642900E-03 |
| Normal-vs-Stage3 |
5.439100E-03 |
| Normal-vs-Stage4 |
4.922300E-03 |
| Stage1-vs-Stage2 |
8.730000E-01 |
| Stage1-vs-Stage3 |
2.891600E-01 |
| Stage1-vs-Stage4 |
8.358000E-01 |
| Stage2-vs-Stage3 |
5.657400E-01 |
| Stage2-vs-Stage4 |
9.747200E-01 |
| Stage3-vs-Stage4 |
5.692200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.768800E-04 |
| Normal-vs-AfricanAmerican |
9.660800E-03 |
| Normal-vs-Asian |
4.457300E-03 |
| Caucasian-vs-AfricanAmerican |
2.118400E-01 |
| Caucasian-vs-Asian |
7.474200E-01 |
| AfricanAmerican-vs-Asian |
3.975800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.605100E-04 |
| Normal-vs-Female |
4.07719999999667E-05 |
| Male-vs-Female |
9.290800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.48399999999149E-05 |
| Normal-vs-Age(41-60Yrs) |
1.101550E-03 |
| Normal-vs-Age(61-80Yrs) |
4.600300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.080180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.508760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.970800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.747400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.137600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.858400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.821400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.617200E-01 |
| Classical-VS-Follicular |
1.168430E-01 |
| Classical-VS-Other |
8.059800E-01 |
| Classical-VS-Normal |
4.03739999998987E-06 |
| Tall-VS-Follicular |
2.210400E-01 |
| Tall-VS-Other |
6.705000E-01 |
| Tall-VS-Normal |
8.635600E-04 |
| Follicular-VS-Other |
7.854400E-01 |
| Follicular-VS-Normal |
1.529840E-02 |
| Other-VS-Normal |
1.117200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.117400E-03 |
| Normal-vs-N1 |
6.895900E-03 |
| N0-vs-N1 |
4.371400E-01 |
|
|
